Evidence map›Paper›PMID 23813234›Full record

ArticleJournal of fluorescence2013

Sensitized near-infrared luminescence from Nd(III), Yb(III) and Er(III) complexes by energy-transfer from ruthenium 1,3-Bis([1,10]phenanthroline-[5,6-d]-imidazol-2 -yl)benzene.

Subramanian Singaravadivel, Murugesan Velayudham, Eththilu Babu, Paulpandian Muthu Mareeswaran, Kuang-Lieh Lu, Seenivasan Rajagopal

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of fluorescence, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Subramanian SingaravadivelSchool of Chemistry, Madurai Kamaraj University, Madurai, India.
Murugesan Velayudham
Eththilu Babu
Paulpandian Muthu Mareeswaran
Kuang-Lieh Lu
Seenivasan Rajagopal

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The luminescent ruthenium 1,3 -bis([1,10]phenanthroline-[5,6 -d]- imidazol-2 -yl)benzene (bpibH2) complex, a potentially useful bridging ligand with a vacant diimine site, has been used as 'metallo ligand' to make heterodinuclear d-f complexes by attachment of a {Ln(dik)3} fragment (dik = 1,3-diketonate) at the vacant site. When Ln = Nd, Yb, or Er the lanthanide centre has low-energy f-f excited states capable of accepting energy from the (3)MLCT excited state of the Ru(II) centre, there is quenching in the (3)MLCT luminescence of the Ru(II) centre, that affords sensitized lanthanide(III) based luminescence in the near-IR region. Nd(III) was found to be the most effective at quenching the (3)MLCT luminescence of the ruthenium component because of the high density of f-f excited states of the appropriate energy which make it as effective energy-acceptor compared to Er and Yb complexes.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.